No Data
Ojing Healthcare: 2024 Earnings Forecast Loss Announcement
Aojing Medical (688613.SH): Expected loss of 17.5559 million yuan in 2024.
On January 24, Gelonghui announced that Ao Jing Medical (688613.SH) released a preliminary loss announcement for its 2024 annual performance. According to initial calculations by the financial department, it is expected to achieve a revenue of 205.6091 million yuan in 2024, with a net income attributable to the owners of the parent company of -17.5559 million yuan, indicating a loss. Additionally, compared to a net income attributable to the owners of the parent company of 54.2318 million yuan (legally disclosed data) from the previous year, it is expected to decrease by 71.7877 million yuan, representing a year-on-year decline of 132.37%. Initial calculations by the financial department also suggest that it is expected to achieve net income in 2024.
Allgens Medical Technology CO., LTD.'s (SHSE:688613) Popularity With Investors Is Under Threat From Overpricing
Aojing Healthcare: Aojing Healthcare: Report for the Third Quarter of 2024
Ojing Healthcare: third quarter report 2024
Aokes Medical (688613.SH) released its performance for the first three quarters, with a net income of 4.8882 million yuan, a year-on-year decrease of 90.95%.
Aokang Medical (688613.SH) disclosed its third quarter report for 2024, achieving operating revenue in the first three quarters...
Declining Stock and Decent Financials: Is The Market Wrong About Allgens Medical Technology CO., LTD. (SHSE:688613)?